Physician profile
David W Dozer
NPI 1598727430
$2,503.95
in general payments reported to CMS, 2019-2025
18 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $267 · 2021: $227 · 2022: $582 · 2023: $351 · 2024: $213 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,344.71 | 2019-2025 | Skyrizi, Rinvoq, Viberzi |
| Boston Scientific Corporation | $321.25 | 2021-2023 | Exalt Model D |
| Medtronic, INC. | $134.03 | 2025 | Endoflip |
| Medtronic USA, INC. | $98.30 | 2019 | |
| Lumendi LLC | $85.77 | 2019 | |
| Capsovision, INC. | $74.74 | 2024 | Capsocam Plus |
| Janssen Biotech, INC. | $74.29 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $70.78 | 2019-2020 | |
| Erbe USA INC | $59.68 | 2022 | |
| Covidien LP | $59.10 | 2019 | |
| Ironwood Pharmaceuticals, INC | $41.65 | 2019-2020 | |
| Celgene Corporation | $34.93 | 2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.41 | 2019 | |
| Shire North American Group INC | $16.92 | 2019 | |
| Merck Sharp & Dohme LLC | $15.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Echosens North America, INC. | $14.98 | 2023 | Fibroscan |
| Braintree Laboratories, INC. | $14.26 | 2020 | |
| Allergan, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dozer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.